Pharmafile Logo
Pharmafocus logo
Advanced Search

EFPIA

Showing 15 posts of 51 posts found.

Sanofi image

Sanofi chief executive to lead EFPIA

June 26, 2013
Research and Development, Sales and Marketing EFPIA, GSK, Sanofi, Viehbacher, Witty

Chief executive of Sanofi Christopher Viehbacher has been elected to serve as president of the European Federation of Pharmaceutical Industries …

News
ABPI image

ABPI supply chain warning

March 7, 2013
Manufacturing and Production, Sales and Marketing ABPI, API, EFPIA

The ABPI is warning of supply chain problems which may cause a bottleneck in UK pharma manufacture this summer. The …

News
UCB image

UCB warns of data ‘voyeurism’

February 27, 2013
Research and Development, Sales and Marketing EFPIA, UCB, VBP, transparancy

UCB chief executive Roch Doliveux has attacked the idea of making all clinical trial data publicly available, saying it could …

News

£20m research boost for Scottish biotech

February 11, 2013
Research and Development, Sales and Marketing Bayer, BioCity Scotland, Dundee, EFPIA

BioCity Scotland and the University of Dundee are to play key roles in a newly-launched pan-European drug discovery project. In …

News
Bayer image

New boost for drug candidates

December 5, 2012
Research and Development, Sales and Marketing Bayer, EFPIA, K4DD, Leiden

A new project is trying to increase the hit rates of successful drug candidates by improving the way they are …

News
EMA image

EMA’s five points on data release

November 27, 2012
Medical Communications, Research and Development, Sales and Marketing EFPIA, EMA, Rasi, transparency

The European Medicines Agency has highlighted five areas that need to be ironed out before it begins publishing clinical trial …

News

EFPIA rejects ‘indiscriminate’ transparency

November 16, 2012
Medical Communications, Research and Development, Sales and Marketing EFPIA, Goldacre, transparency, trials

Europe’s pharma trade body has poured tepid water on the idea of open access to clinical trial data, saying that …

News

Europe looking to revamp clinical trial laws

July 25, 2012
Research and Development, Sales and Marketing EFPIA, EU, Europe, clinical trials

The European Commission has put forward new proposals aimed at revamping clinical trial laws. The legislation will replace rules that …

News
Witty image

Witty warns EU leaders over pricing

June 27, 2012
Sales and Marketing EFPIA, EU, GSK, Greece, R&D, Witty, pricing

Sir Andrew Witty has waded into the debate over Europe’s economic future with a plea for pharma innovation to be …

News

Pharma calls for urgent change in German system

June 8, 2012
Sales and Marketing AMNOG, EFPIA, Germany, Trajenta, VFA

Europe’s pharma industry has called on the German government to re-think its approach to pricing, saying it is could cause …

News
Richard Bergstrom

Public-private alliance to discover new antibiotics

May 25, 2012
AstraZeneca, EFPIA, GSK, Janssen, Sanofi, antibiotic, bacterial infection

 A Europe-wide public-private partnership is to put €224m (£180m) into finding new antibiotics for all manner of bacterial infections such …

News

Industry supports bid to revitalise antibiotic research

November 17, 2011
Research and Development, Sales and Marketing EFPIA, Europe, IMI, antibiotic

The European Commission and the European pharma industry have unveiled plans to accelerate the discovery and development of new antibiotics. …

News

Price transparency and timing at risk, warns EFPIA

June 9, 2011
Sales and Marketing Drug pricing, EFPIA, medicines pricing, pricing

Europe’s pharmaceutical industry has warned that a review of EU law could undermine the pricing and reimbursement of medicines. The …

News
efpia_lif_richard_bergstrom

Richard Bergström takes DG role at EFPIA

March 18, 2011
Research and Development, Sales and Marketing Brian Ager, EFPIA, Richard Bergstrom, appointment, research and development, sales and marketing

European pharma industry association EFPIA has appointed Richard Bergström as its new director general. He takes over from Brian Ager, …

Appointment
Counterfeit Plavix

Europe votes in new anti-counterfeit law

February 21, 2011
Manufacturing and Production EFPIA, counterfeits, supply chain

The European Parliament has voted in favour of the Falsified Medicines Directive to help stop the flow of counterfeit medicines …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025